The Discovery of Sotorasib (AMG 510): First-in-Class Investigational Covalent Inhibitor of KRAS G12C - American Chemical Society
The Discovery of Sotorasib (AMG 510): First-in-Class Investigationa…
Dec 7, 2022
acs.org
NSCLC: Sotorasib in Practice | OncLive
NSCLC: Sotorasib in Practice | OncLive
1 week ago
onclive.com
WCLC 2025 Summary: Oncogene-Addicted NSCLC - Taletrectinib (ROS1 ), Sotorasib (KRAS G12C), Zipalertinib (EGFR exon 20), Sevabertinib/Zongertinib (HER2m)
WCLC 2025 Summary: Oncogene-Addicted NSCLC - Taletrectinib (R…
3 months ago
vumedi.com
[Hot Item] Amg 510 High Quality CAS 2252403-56-6 Amg 510 Sotorasib
[Hot Item] Amg 510 High Quality CAS 2252403-56-6 Amg 510 Sotor…
3 months ago
made-in-china.com
Tumore dei polmoni, efficace la pillola mirata Sotorasib: lo studio
1:38
Tumore dei polmoni, efficace la pillola mirata Sotorasib: lo studio
May 10, 2022
sky.it
Tumore al polmone, rimborsato in Italia Sotorasib
Tumore al polmone, rimborsato in Italia Sotorasib
Jun 28, 2024
askanews.it
Tumore al polmone, rimborsato in Italia Sotorasib
Tumore al polmone, rimborsato in Italia Sotorasib
Jul 1, 2024
Il Sole 24 ORE
Targeted Therapy in ROS-1 & KRAS-Mutated Advanced NSCLC: Effica…
3 months ago
vumedi.com
Sotorasib funziona nel tumore del polmone NSCLC avanzato | Milano…
Mar 2, 2021
milanofinanza.it
Sotorasib in the Treatment of KRAS G12C–Mutant NSCLC
Sep 12, 2023
onclive.com
2:11
Sotorasib is approved in the United States to treat KRAS p.G12C–mut…
2.6K viewsJan 4, 2023
FacebookThe New England Journal of Medicine
Sotorasib: New drug that destroys lung cancer
Nov 4, 2021
news4jax.com
FDA Approves Sotorasib Plus Panitumumab for KRAS G12C–Mu…
1 week ago
onclive.com
Dr Goldberg on the Investigation of VIC-1911 With/Without Sotorasib i…
Jul 21, 2023
onclive.com
Dr. Dy on the Use of Sotorasib in KRAS G12C–Mutated NSCLC
Apr 10, 2022
onclive.com
Dr Strickler on the Efficacy of Sotorasib Plus Panitumumab/Che…
8 months ago
onclive.com
Dr. Iams on the Evaluation of Sotorasib in KRAS G12C–Mutant …
Aug 7, 2022
onclive.com
Dr Fakih on the FDA Approval of Sotorasib Plus Panitumumab for …
1 year ago
onclive.com
Dr Fakih on OS Data for Sotorasib Plus Panitumumab in KRAS G12C…
2 weeks ago
onclive.com
Dr Yaeger on the Implications of Data With Second-Line Sotorasib …
Feb 27, 2024
onclive.com
12:56
Clinical Cases #128 - Adenocarcinoma polmonare e sot…
13 views1 month ago
YouTubeOncoInfoTV
7:12
How Quantum Computing Designs Cancer Drugs? | KRAS & Sotorasi…
71 views1 month ago
YouTubeChemPharmaAcademy
索托拉西布(Sotorasib、LUMAKRAS)药品信息展示【海鸥 …
2 months ago
sohu
1:29
【赴宜康】索托拉西布(Sotorasib)说明书核心内容介绍，效果数据
4 views1 month ago
bilibili赴宜康医药查询
ESMO highlights: KRAS G12C inhibitors
700 viewsOct 20, 2022
YouTubeVJOncology
CodeBreak 100: assessing sotorasib in patients with KRAS p.G12C-mut…
374 viewsJun 7, 2022
YouTubeVJOncology
Sotorasib – Mechanism of Action and Synthesis
2.8K viewsSep 9, 2023
YouTubeOrganic Chemistry with Lluís Llorens Palomo
Tumore al polmone, rimborsato in Italia Sotorasib
Jun 28, 2024
iltempo.it
Sotorasib vs. Adagrasib as Treatment for KRAS G12C Mutate…
872 viewsApr 28, 2023
YouTubeGlobal Resource for Advancing Cancer Education
Sotorasib: New Drug Destroys Lung Cancer
May 14, 2024
MSN
See more videos
Static thumbnail place holder